Cargando…

p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells

The restoration of p53 has been suggested as a therapeutic approach in tumors. However, the timing of p53 restoration in relation to its efficacy during tumor progression still is unclear. We now show that the restoration of p53 in murine premalignant proliferating pineal lesions resulted in cellula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harajly, Mohamad, Zalzali, Hasan, Nawaz, Zafar, Ghayad, Sandra E., Ghamloush, Farah, Basma, Hussein, Zainedin, Samiha, Rabeh, Wissam, Jabbour, Mark, Tawil, Ayman, Badro, Danielle A., Evan, Gerard I., Saab, Raya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719431/ https://www.ncbi.nlm.nih.gov/pubmed/26598601 http://dx.doi.org/10.1128/MCB.00747-15

Ejemplares similares

The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
por: Ghamloush, Farah, et al.
Publicado: (2019)

CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma
por: Fahs, Assil, et al.
Publicado: (2022)

Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts
por: Ghayad, Sandra E., et al.
Publicado: (2016)

Temporally distinct roles for tumor suppressor pathways in cell cycle arrest and cellular senescence in Cyclin D1-driven tumor
por: Zalzali, Hasan, et al.
Publicado: (2012)

Effects of the Oncoprotein PAX3-FOXO1 on Modulation of Exosomes Function and Protein Content: Implications on Oxidative Stress Protection and Enhanced Plasticity
por: Fahs, Assil, et al.
Publicado: (2020)

Non-coding RNA in rhabdomyosarcoma progression and metastasis
por: Ramadan, Farah, et al.
Publicado: (2022)

Senescence program and its reprogramming in pancreatic premalignancy
por: Yang, Kailing, et al.
Publicado: (2023)

Cellular Senescence: Many Roads, One Final Destination
por: Saab, Raya
Publicado: (2010)

A Pro-Regenerative Environment Triggers Premalignant to Malignant Transformation of Senescent Hepatocytes
por: Wuestefeld, Anna, et al.
Publicado: (2023)

DNA integrity in diagnosis of premalignant lesions
por: Azab, Noha Adel, et al.
Publicado: (2021)

Oral Premalignancy
por: Hume, W.
Publicado: (1981)

Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions
por: Kolodkin-Gal, Dror, et al.
Publicado: (2022)

Are Hepatic Adenomas Premalignant?
por: Nagorney, David M.
Publicado: (1996)

Premalignant conditions of bone
por: Horvai, Andrew, et al.
Publicado: (2006)

Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001)

Premalignant Conditions of Bone
por: Eckhoff, Michael D., et al.
Publicado: (2022)

Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007)

Premalignant male genital dermatoses
por: Singhal, Rochit Rajesh, et al.
Publicado: (2019)

Extracellular Prostaglandins E1 and E2 and Inflammatory Cytokines Are Regulated by the Senescence Program in Potentially Premalignant Oral Keratinocytes
por: Karen-Ng, Lee Peng, et al.
Publicado: (2022)

Targeting proteostasis maintenance and autophagy in senescence
por: L’Hôte, Valentin, et al.
Publicado: (2022)

Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy
por: Lenci, Marco Antonio, et al.
Publicado: (2014)

Premalignant Lesions as Targets for Cancer Vaccines
por: Finn, Olivera J.
Publicado: (2003)

Zoon's Balanitis: Benign or Premalignant Lesion?
por: Balato, Nicola, et al.
Publicado: (2009)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Adjunctive aids for the detection of oral premalignancy
por: Charanya, D., et al.
Publicado: (2016)

Cutaneous Horn in Premalignant and Malignant Conditions
por: Park, Hyochun, et al.
Publicado: (2016)

Mutation Profiling of Premalignant Colorectal Neoplasia
por: Karczmarski, Jakub, et al.
Publicado: (2019)

A juvenile polyp on colonoscopy, is it premalignant?
por: Kumar, Kishore, et al.
Publicado: (2019)

Editorial: Premalignant conditions in the esophagus and stomach
por: Tustumi, Francisco, et al.
Publicado: (2022)

Frequency of cervical premalignant lesions in the gynecologic patients of a tertiary hospital in Mogadishu, Somalia
por: Kurtay, Sabri, et al.
Publicado: (2022)

PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin(Y654)
por: Gao, Chenxi, et al.
Publicado: (2019)

E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study
por: Kalaimani, Gnanambigai, et al.
Publicado: (2023)

Cystitis glandularis: A controversial premalignant lesion
por: YI, XIANLIN, et al.
Publicado: (2014)

Association of immunohistochemical markers with premalignancy in Gonadal Dysgenesis
por: McCann-Crosby, Bonnie, et al.
Publicado: (2015)

The somatic mutation landscape of premalignant colorectal adenoma
por: Lin, Shu-Hong, et al.
Publicado: (2018)

Redirecting the focus of cancer immunotherapy to premalignant conditions
por: Young, M. Rita I.
Publicado: (2017)

Immunological and classical subtypes of oral premalignant lesions
por: Foy, Jean-Philippe, et al.
Publicado: (2018)

Cryotherapy in the management of premalignant and malignant conditions of the esophagus
por: Lal, Pooja, et al.
Publicado: (2018)

Premalignant lesions and gastric cancer: Current understanding
por: Koulis, Athanasios, et al.
Publicado: (2019)

Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis
por: Georgaki, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vocrm1iknqkfo82mnkckaod54